First Cocoa Extract from Naturex, Barry Callebaut Collaboration Hits Market


The new CocoActiv extract contains 300 times more flavanols than regular chocolate, according to Naturex.

Image provided by Naturex.

Image provided by Naturex.

The collaboration between cocoa supplier Barry Callebaut (Zurich, Switzerland) and botanicals firm Naturex (Avignon, France) has yielded its first cocoa extract designed for the heart-health supplements market. The new high-flavanol CocoActiv ingredient, which launched a few weeks before the recent Vitafoods Europe 2016 trade show, contains 300 times more flavanols than regular chocolate and allows for a 13.5 EFSA health claim relating to heart health, Naturex says.

Late last year, Barry Callebaut and Naturex signed a five-year licensing agreement under which Naturex will produce and market purified cocoa extract from Barry Callebaut’s unique, flavanol-rich cocoa beans for the heart-health food-supplements sector. A central part of the agreement is Naturex’s right to market the ingredient with the proprietary 13.5 EFSA health claim, “cocoa flavanols help maintain the elasticity of blood vessels, which contributes to normal blood flow.”

Currently, the 13.5 health claim applies to dietary supplements only, so CocoActiv is designed mainly for use in tablets, capsules, or gummies, according to Elizabeth Bui, director of the nutrition & health business unit at Naturex.


Read more:

Different Paths to Clean-Label Cocoa

Cocoa Flavanols: Emerging Research Is Taking Us Deeper Inside the Cacao Bean

Naturex Will Leverage Cocoa Flavanols EU Health Claim for Heart Health


Michael Crane
Associate Editor
Nutritional Outlook Magazine

Related Videos
Nils Hoem and Nutritional Outlook editor Sebastian Krawiec
woman working on laptop computer by window
Related Content
© 2024 MJH Life Sciences

All rights reserved.